154 related articles for article (PubMed ID: 20002873)
21. Investigation of the SH3BP2 gene mutation in cherubism.
Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
[TBL] [Abstract][Full Text] [Related]
22. [Genetic aspects of cherubism].
Brix M; Peters H; Ranfaing E; Ricbourg B
Rev Stomatol Chir Maxillofac; 2006 Apr; 107(2):105-8. PubMed ID: 16738517
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-Src and comparison of cytologic features in cherubism, central giant cell granuloma and giant cell tumors.
Wang C; Song Y; Peng B; Fan M; Li J; Zhu S; Bian Z
Oncol Rep; 2006 Mar; 15(3):589-94. PubMed ID: 16465417
[TBL] [Abstract][Full Text] [Related]
24. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws. A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis.
Tosios KI; Gopalakrishnan R; Koutlas IG
Head Neck Pathol; 2008 Dec; 2(4):333-8. PubMed ID: 20614305
[TBL] [Abstract][Full Text] [Related]
25. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
26. [Cherubism: pathology and diagnosis. Analysis of 7 cases].
Dominguez FV; Keszler A
Rev Asoc Odontol Argent; 1984 Aug; 72(5):136-8, 140, 142-5. PubMed ID: 6599133
[No Abstract] [Full Text] [Related]
27. [Cherubism: regression of the lesions and spontaneous bone regeneration].
Timosca GC
Rev Stomatol Chir Maxillofac; 1996; 97(3):172-7. PubMed ID: 8711332
[TBL] [Abstract][Full Text] [Related]
28. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
29. Diseases affecting the jaws. 3. Giant cell lesions and fibrous dysplasia of the jaws.
Batsakis JG; Rice DH
Univ Mich Med Cent J; 1969; 35(3):162-9. PubMed ID: 5384684
[No Abstract] [Full Text] [Related]
30. [Cherubism].
Brix M; Peters H; Lebeau J
Rev Stomatol Chir Maxillofac; 2009 Nov; 110(5):293-8. PubMed ID: 19836038
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart.
Zhou B; Wu B; Tompkins KL; Boyer KL; Grindley JC; Baldwin HS
Development; 2005 Mar; 132(5):1137-46. PubMed ID: 15689382
[TBL] [Abstract][Full Text] [Related]
32. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
[TBL] [Abstract][Full Text] [Related]
33. RGS18 acts as a negative regulator of osteoclastogenesis by modulating the acid-sensing OGR1/NFAT signaling pathway.
Iwai K; Koike M; Ohshima S; Miyatake K; Uchiyama Y; Saeki Y; Ishii M
J Bone Miner Res; 2007 Oct; 22(10):1612-20. PubMed ID: 17576169
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
Guimarães LM; Baumhoer D; Andrei V; Friedel D; Koelsche C; Gomez RS; von Deimling A; Gomes CC
J Pathol Clin Res; 2023 Nov; 9(6):464-474. PubMed ID: 37555357
[TBL] [Abstract][Full Text] [Related]
35. Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.
Ueki Y; Lin CY; Senoo M; Ebihara T; Agata N; Onji M; Saheki Y; Kawai T; Mukherjee PM; Reichenberger E; Olsen BR
Cell; 2007 Jan; 128(1):71-83. PubMed ID: 17218256
[TBL] [Abstract][Full Text] [Related]
36. Cherubism: a differential diagnosis of multinucleate giant cell lesions of jaw.
Bindu S; Mulay S; Kulkarni D
Indian J Pathol Microbiol; 2001 Oct; 44(4):489-90. PubMed ID: 12035376
[No Abstract] [Full Text] [Related]
37. Systemic leukocyte activation in patients with central giant cell lesions.
de Souza PE; Gomez RS; Xavier GM; dos Santos JS; Gollob KJ; Dutra WO
J Oral Pathol Med; 2005 May; 34(5):312-7. PubMed ID: 15817076
[TBL] [Abstract][Full Text] [Related]
38. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
39. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
40. The molecular understanding of osteoclast differentiation.
Asagiri M; Takayanagi H
Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
